Thanks for the writeup! They have performed well last 6 quarters. It will be interesting to see how their GLR will develop next 4 quarters and will they improve their cross selling. Still less than 5% of their customers have multiple policies.
Great Q1 from GLR TTM perspective. Flat despite CA fires, wow! Cross selling still very low. 2670k policies for 2545k customers. 4,9% cross sell vs 4,8% in Q4.24. Huge potential remains, still not unlocked.
True that! Currently I find following of their FCF quite difficult due to their synthetic agents CAC financing program, so I’m focused on following up IFP growth, GLR TTM and cross sales (total of customers per product minus total customers).
Thanks for the writeup! They have performed well last 6 quarters. It will be interesting to see how their GLR will develop next 4 quarters and will they improve their cross selling. Still less than 5% of their customers have multiple policies.
Good point! Synthetic agents improve FCF (but not EBIT)… anyway I like the KPIs you are following, let’s keep in touch!
Great Q1 from GLR TTM perspective. Flat despite CA fires, wow! Cross selling still very low. 2670k policies for 2545k customers. 4,9% cross sell vs 4,8% in Q4.24. Huge potential remains, still not unlocked.
Absolutely 💯 I’ll be working on the Q1 update soon! Stay tuned
I agree, a fundamental edge against companies like ROOT is the possibility to cross sell on the customer base.
True that! Currently I find following of their FCF quite difficult due to their synthetic agents CAC financing program, so I’m focused on following up IFP growth, GLR TTM and cross sales (total of customers per product minus total customers).